Prevalence of COPD Stable Overall From 2011 to 2021
Prevalence stable for most states and subgroups, but increased in those aged ≥75, micropolitan counties, current and former smokers
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy
Asthma-Linked Health Care Use Increased With Non-English Speaking Caregivers
Caregiver non-English language preference linked to increased use of asthma-related ED visit, hospitalization, ICU visit
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
Physical Activity Inversely Tied to COPD Symptom Burden
Findings seen even in patients with mild or previously undiagnosed disease
Preexisting Allergic Disease May Increase Risk for Long COVID
Systematic literature review identifies increased risk but with very low certainty
Rate of New Lung Cancer Cases Has Decreased Over Last Five Years
26.6 percent of people alive five years after a lung cancer diagnosis, with 22 percent improvement seen over last five years
Virologic Rebound Occurs in ~20 Percent Receiving Nirmatrelvir-Ritonavir
Virologic rebound more common among those who started therapy within two days of symptom onset
ACAAI: Mold After Natural Disasters Poses Great Risk to Allergy Patients
High-efficiency particulate air filters are most effective for removing airborne particles
Gender Life Expectancy Gap Increased From 2010 to 2021
Leading contributors to widening gender life expectancy gap from 2019 to 2021 included COVID-19, unintentional injuries
